Molecular Mechanism Underlying Effects of Wumeiwan on Steroid-Dependent Asthma: A Network Pharmacology, Molecular Docking, and Experimental Verification Study.


Journal

Drug design, development and therapy
ISSN: 1177-8881
Titre abrégé: Drug Des Devel Ther
Pays: New Zealand
ID NLM: 101475745

Informations de publication

Date de publication:
2022
Historique:
received: 18 11 2021
accepted: 15 02 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

Steroid-dependent asthma (SDA) is characterized by oral corticosteroid (OCS) resistance and dependence. Wumeiwan (WMW) showed potentials in reducing the dose of OCS of SDA patients based on our previous studies. Network pharmacology was conducted to explore the molecular mechanism of WMW against SDA with the databases of TCMSP, STRING, etcetera. GO annotation and KEGG functional enrichment analysis were conducted by metascape database. Pymol performed the molecular docking. In the experiment, the OVA-induced plus descending dexamethasone intervention chronic asthmatic rat model was conducted. Lung pathological changes were analyzed by H&E, Masson, and IHC staining. Relative expressions of the gene were performed by real-time PCR. A total of 102 bioactive ingredients in WMW were identified, as well as 191 common targets were found from 241 predicted targets in WMW and 3539 SDA-related targets. The top five bioactive ingredients were identified as pivotal ingredients, which included quercetin, candletoxin A, palmidin A, kaempferol, and beta-sitosterol. Besides, 35 HUB genes were obtained from the PPI network, namely, WMW could be a complementary and alternative therapy for SDA by reducing airway inflammation.

Sections du résumé

Background UNASSIGNED
Steroid-dependent asthma (SDA) is characterized by oral corticosteroid (OCS) resistance and dependence. Wumeiwan (WMW) showed potentials in reducing the dose of OCS of SDA patients based on our previous studies.
Methods UNASSIGNED
Network pharmacology was conducted to explore the molecular mechanism of WMW against SDA with the databases of TCMSP, STRING, etcetera. GO annotation and KEGG functional enrichment analysis were conducted by metascape database. Pymol performed the molecular docking. In the experiment, the OVA-induced plus descending dexamethasone intervention chronic asthmatic rat model was conducted. Lung pathological changes were analyzed by H&E, Masson, and IHC staining. Relative expressions of the gene were performed by real-time PCR.
Results UNASSIGNED
A total of 102 bioactive ingredients in WMW were identified, as well as 191 common targets were found from 241 predicted targets in WMW and 3539 SDA-related targets. The top five bioactive ingredients were identified as pivotal ingredients, which included quercetin, candletoxin A, palmidin A, kaempferol, and beta-sitosterol. Besides, 35 HUB genes were obtained from the PPI network, namely,
Conclusion UNASSIGNED
WMW could be a complementary and alternative therapy for SDA by reducing airway inflammation.

Identifiants

pubmed: 35386850
doi: 10.2147/DDDT.S349950
pii: 349950
pmc: PMC8978578
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

909-929

Informations de copyright

© 2022 Lyu et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Crit Rev Food Sci Nutr. 2020;60(19):3290-3303
pubmed: 31680558
Respir Med. 2005 Feb;99(2):200-7
pubmed: 15715187
J Mol Med (Berl). 2020 Mar;98(3):361-374
pubmed: 31974640
Eur J Pharmacol. 2011 Jan 10;650(1):458-64
pubmed: 20946894
Respir Res. 2018 Sep 3;19(1):168
pubmed: 30176850
QJM. 2022 Jan 9;114(12):857-864
pubmed: 32821936
Microb Cell Fact. 2017 Sep 26;16(1):165
pubmed: 28950867
PLoS One. 2015 Oct 30;10(10):e0141909
pubmed: 26517722
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302
pubmed: 24200404
J Clin Invest. 2019 Feb 1;129(2):744-758
pubmed: 30640172
Evid Based Complement Alternat Med. 2020 Jan 8;2020:5196302
pubmed: 32025235
Mol Biol Rep. 2016 Jul;43(7):697-710
pubmed: 27188427
Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33
pubmed: 27322403
Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:85-94
pubmed: 28053519
J Allergy Clin Immunol. 2018 Feb;141(2):560-570
pubmed: 28528200
World J Gastroenterol. 2005 Aug 21;11(31):4800-6
pubmed: 16097047
BMC Bioinformatics. 2014 Aug 29;15:293
pubmed: 25176396
Eur Respir J. 2018 Oct 25;52(4):
pubmed: 30190274
Inflamm Res. 2012 May;61(5):521-33
pubmed: 22327510
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Front Pharmacol. 2019 Oct 09;10:1185
pubmed: 31649545
Eur Respir J. 2010 Apr;35(4):750-6
pubmed: 19840967
Front Cell Dev Biol. 2021 Feb 18;9:638366
pubmed: 33681222
Cell. 2021 Apr 29;184(9):2521-2522
pubmed: 33930297
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Front Pharmacol. 2019 Feb 21;10:123
pubmed: 30846939
Genes Cancer. 2011 Apr;2(4):385-91
pubmed: 21779507
DNA Repair (Amst). 2020 Nov;95:102952
pubmed: 32846356
Biomed Pharmacother. 2021 May;137:111383
pubmed: 33761604
Ann Transl Med. 2021 Jan;9(2):164
pubmed: 33569466
BMC Complement Altern Med. 2019 Jan 31;19(1):35
pubmed: 30704457
Thorax. 2008 Sep;63(9):784-90
pubmed: 18492738
PLoS One. 2015 Apr 23;10(4):e0124961
pubmed: 25905622
Neurol Res. 2022 Apr;44(4):318-330
pubmed: 34592910
Curr Opin Pulm Med. 2019 Jan;25(1):51-58
pubmed: 30461530
Int Immunopharmacol. 2019 Sep;74:105718
pubmed: 31255882
Nucleic Acids Res. 2021 Jan 8;49(D1):D437-D451
pubmed: 33211854
Lancet Respir Med. 2020 May;8(5):461-474
pubmed: 32066536
J Ethnopharmacol. 2020 Apr 24;252:112580
pubmed: 31972322
J Clin Med. 2020 Nov 18;9(11):
pubmed: 33217964
Int Arch Allergy Immunol. 2012;158 Suppl 1:96-102
pubmed: 22627375
Exp Biol Med (Maywood). 2015 Apr;240(4):498-507
pubmed: 25519430
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S28-38
pubmed: 11734464
Chest. 2011 Jun;139(6):1470-1479
pubmed: 21652557
Yao Xue Xue Bao. 2015 Jun;50(6):702-7
pubmed: 26521440
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1094-101
pubmed: 25162311
Expert Rev Respir Med. 2019 Nov;13(11):1057-1068
pubmed: 31498708
N Engl J Med. 2018 Jun 28;378(26):2475-2485
pubmed: 29782224
Nucleic Acids Res. 2020 Jan 8;48(D1):D1031-D1041
pubmed: 31691823
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Molecules. 2016 May 12;21(5):
pubmed: 27187333
Am J Physiol Lung Cell Mol Physiol. 2003 Apr;284(4):L566-77
pubmed: 12618418
Phytother Res. 2021 Sep;35(9):5103-5124
pubmed: 33957012
J Allergy Clin Immunol. 2017 Aug;140(2):395-406
pubmed: 27931975
Am J Respir Crit Care Med. 2020 Feb 1;201(3):276-293
pubmed: 31525297
J Integr Med. 2020 Nov;18(6):530-534
pubmed: 32928700
Cell Signal. 2011 Oct;23(10):1515-27
pubmed: 21620960
Allergy Asthma Proc. 2020 May 1;41(3):151-157
pubmed: 32375958
Eur Respir J. 2014 Nov;44(5):1319-31
pubmed: 24925921
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Eur J Pharmacol. 2021 Jan 15;891:173698
pubmed: 33129789
Comput Biol Chem. 2021 Feb;90:107402
pubmed: 33338839
Phytother Res. 2019 Feb;33(2):263-275
pubmed: 30402931
Sci Rep. 2017 Aug 30;7(1):9919
pubmed: 28855674
Thorax. 2010 Sep;65(9):787-94
pubmed: 20805172
Front Med (Lausanne). 2017 Sep 26;4:158
pubmed: 29018800
Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L701-9
pubmed: 21378028
Nucleic Acids Res. 2020 Jan 8;48(D1):D845-D855
pubmed: 31680165
Nucleic Acids Res. 2011 Jan;39(Database issue):D1055-9
pubmed: 21097881
Respir Med. 2019 Jul - Aug;154:144-154
pubmed: 31260861
Phytomedicine. 2020 Jun 3;76:153258
pubmed: 32563018
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Chin J Nat Med. 2021 Jan;19(1):1-11
pubmed: 33516447
J Cheminform. 2014 Apr 16;6:13
pubmed: 24735618
J Allergy Clin Immunol. 2015 Oct;136(4):962-970.e1
pubmed: 26044855
FASEB J. 2000 Jul;14(10):1362-74
pubmed: 10877829
Ann Allergy Asthma Immunol. 2007 Oct;99(4):291-302; quiz 302-3, 370
pubmed: 17941275
Inflamm Res. 2007 May;56(5):210-5
pubmed: 17588137
Sci Rep. 2016 Feb 16;6:21146
pubmed: 26879404
Am J Clin Nutr. 2002 Sep;76(3):560-8
pubmed: 12198000
Life Sci. 2017 Feb 1;170:1-8
pubmed: 27916734

Auteurs

Mingsheng Lyu (M)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Yahui Wang (Y)

Department of Neurology and Stroke Center, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Qiuyi Chen (Q)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Jingbo Qin (J)

National Institute of TCM Constitution and Preventive Medicine, School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Dan Hou (D)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Shuaiyang Huang (S)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Dongmei Shao (D)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Xuefeng Gong (X)

Department of Traditional Chinese Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.

Guirui Huang (G)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Shiyu Zhang (S)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Zhijie Zhang (Z)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Hongsheng Cui (H)

Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH